NanoEntek Participates in Middle East's Largest Diagnostic Exhibition 'Medlab 2023'

[Asia Economy Reporter Hyungsoo Park] NanoEntek announced on the 6th that it will participate in the international diagnostic specialist exhibition 'Medlab Middle East 2023,' held in Dubai until the 9th.

Now in its 7th year, Medlab is a diagnostic specialist exhibition centered on the Middle East and Africa. Since it is held in Dubai, a trade hub, it provides an opportunity to showcase technology not only to the Middle East and Africa but also to the Indian market.

NanoEntek will operate a promotional booth focusing on discovering new customers in the Middle Eastern diagnostic market. It will showcase various diagnostic products, including the 'Friend System,' a fluorescent immunoassay in vitro diagnostic product approved by the U.S. Food and Drug Administration (FDA), as well as the ADAM series, a blood component analysis system.

Based on the Friend System vitamin D diagnostic product, which has entered Saudi Arabia, the company plans to strengthen its position as a premium product in the Middle Eastern market.

A company representative said, "With the goal of expanding the countries for non-COVID products, we have obtained approval for male hormone diagnostics and Good Manufacturing Practice (GMP)." He added, "We have also entered the Middle Eastern region, including Saudi Arabia." He further stated, "Through participation in the exhibition, we plan to expand our network and solidify our presence in the new Middle Eastern market."